Home » Topics » Regulatory » EMA

EMA
RSS

European orphan drug designation awarded to Betalutin for follicular lymphoma

June 12, 2014

EMA validates MAA for Raxone in Leber's hereditary optic neuropathy

June 6, 2014

EMA grants accelerated assessment to nintedanib MAA for IPF

June 5, 2014

EMA accepts Hetlioz MAA for review

June 4, 2014

EMA's CHMP confirms negative opinion for RLX-030

May 27, 2014

EMA recommends approval of Nuwiq for children and adults with hemophilia A

May 27, 2014

EMA committee hands down positive opinion on Arzerra for CLL

May 27, 2014

EMA's CHMP recommends approval of Simbrinza to reduce IOP

May 27, 2014

EMA committee makes Halaven recommendation

May 27, 2014

CHMP adopts positive opinion for Plegridy as a treatment for multiple sclerosis

May 27, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...